Table 2.
Patient reported outcomes for completers at admission and follow-up (n = 317)
| Admission/Baseline | Departure | 3 months | 6 months | |
|---|---|---|---|---|
| HAQ (0-3) | 1.21 (0.66) | 1.16 (0.67)** | 1.20 (0.66) | 1.22 (0.68) |
| SF-36 PCS (0-100) | 30.3 (10.0) | 31.4 (9.6)** | 31.0 (9.9) | 31.1 (9.6) |
| SF-36 MCS (0-100) | 45.4 (12.4) | 46.9 (11.5)* | 47.3 (11.8)** | 47.3 (11.8)** |
| Pain (0-100) | 49.8 (24.7) | 40.6 (23.6)** | 44.0 (24.2)** | 45.7 (24.6)** |
| Fatigue (0-100) | 59.2 (27.5) | 53.8 (28.3)** | 53.3 (28.0)** | 54.5 (27.5)** |
| Patient global (0-100) | 48.3 (24.8) | 39.6 (22.8)** | 44.5 (24.7)* | 45.4 (24.4)* |
| SES pain (10-100) | 54.0 (16.9) | 57.5 (16.8)** | 54.4 (16.7) | 54.5 (17.1) |
| SES symptoms (10-100) | 61.0 (15.2) | 64.9 (15.3)** | 62.8 (15.6)* | 61.2 (15.8) |
| RADAI (0-10) | 4.5 (2.1) | 3.9 (1.9)** | 4.3 (2.1) | 4.4 (2.1) |
| Utility (SF-6D, 0-1) | 0.596 (0.11) | 0.618 (0.11)** | 0.622 (0.12)** | 0.621 (0.12)** |
Values are means (standard deviation)
*p < 0.05 **p < 0.01 (paired t-test) versus baseline
HAQ Health Assessment Questionnaire, SF-36 Short Form 36, PCS Physical component summary, MCS mental component summary, SES Self-Efficacy Scales, RADAI Rheumatoid Arthritis Disease Activity Index